For example, patients with a HCV genotype 1 infection typically receive Peg-IFN and ribavirin treatment for 48 weeks, while those with HCV genotype 2 or 3 infection are typically treated for 24 weeks.

Before starting treatment, you need to take a simple blood test to learn which genotype you have. Some DAAs can be used to treat all hepatitis C genotypes. Effective direct-acting antiviral or 'DAA' ...

HCV patients currently receive a combination ... Coupled with this, only around 50% of patients with the predominate genotype in the US and Europe, HCV1, achieve a sustained virological response ...

The arrival of interferon-free, orally administered direct-acting antivirals (DAAs) in 2014 was a leap forward for the treatment of hepatitis C (HCV ... specific viral genotype involved[1].

Professor Foster’s work on the natural history and prevalence of genotype 3 HCV showed that there was a higher prevalence of infection and cirrhosis in immigrants, particularly those from the Indian ...